- Home
- CADL vs GFR Comparison
CADL vs GFR Comparison
Compare CADL & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- GFR
- Stock Information
- Founded
- CADL 1999
- GFR 2018
- Country
- CADL United States
- GFR Canada
- Employees
- CADL N/A
- GFR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- GFR
- Sector
- CADL Health Care
- GFR
- Exchange
- CADL Nasdaq
- GFR Nasdaq
- Market Cap
- CADL 278.6M
- GFR 318.9M
- IPO Year
- CADL 2021
- GFR N/A
- Fundamental
- Price
- CADL $5.95
- GFR $4.84
- Analyst Decision
- CADL Strong Buy
- GFR
- Analyst Count
- CADL 5
- GFR 0
- Target Price
- CADL $21.40
- GFR N/A
- AVG Volume (30 Days)
- CADL 627.9K
- GFR 22.8K
- Earning Date
- CADL 08-14-2025
- GFR 08-06-2025
- Dividend Yield
- CADL N/A
- GFR N/A
- EPS Growth
- CADL N/A
- GFR N/A
- EPS
- CADL N/A
- GFR 2.05
- Revenue
- CADL N/A
- GFR $516,308,125.00
- Revenue This Year
- CADL N/A
- GFR N/A
- Revenue Next Year
- CADL N/A
- GFR $16.06
- P/E Ratio
- CADL N/A
- GFR $2.36
- Revenue Growth
- CADL N/A
- GFR N/A
- 52 Week Low
- CADL $3.79
- GFR $3.81
- 52 Week High
- CADL $14.60
- GFR $8.16
- Technical
- Relative Strength Index (RSI)
- CADL 47.68
- GFR 62.44
- Support Level
- CADL $5.45
- GFR $4.14
- Resistance Level
- CADL $6.16
- GFR $4.67
- Average True Range (ATR)
- CADL 0.32
- GFR 0.24
- MACD
- CADL -0.07
- GFR 0.02
- Stochastic Oscillator
- CADL 48.54
- GFR 80.46
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.